The heavy portion of the earnings season is reaching its peak, and daily the indexes are reacting to the releases of the major companies and industries. Here we take a look at the Drug Delivery industry stocks with filings this week. It’s vital for traders to stay informed on which companies are due to report and to know what expectations are for those reports.

Check this out (it's free!): Stocks You Should Be Watching Right Now; How to Make Good Picks

Review of Today’s Market Action
Essential Reading for Traders Here is a selection of articles every successful investor should read and understand: • What you should know before    investing • Understanding the Dow Jones    Industrial Average • Causes of the Credit Crisis • Understanding LIBOR • Relationship of trends in    stocks, bonds and rates • What Drives Mortgage Rates? • Bond Basics • Understanding a Recession • Understanding the LIBOR/OIS    Spread • Smart Dividend Investing

Nektar Therapeutics (NKTR) isn’t the largest stock in the industry, but is the third largest Drug Delivery stock to announce this week. The company will file Wednesday.

Biovail Corporation (BVF) is the biggest announcement (in terms of market cap) in the industry this week on Thursday. The company has posted a 1.66% gain in stock price since about the time of its last earnings release, while the Drug Delivery industry overall has returned -5.55% loss in the same period.

Investors will watch the BVF release closely as it may be an indicator for the Drug Delivery stocks that follow it this week and the overall health of the group.

Also filing and hosting a call this week is Alkermes, Inc. (ALKS) on Thursday. The stock boasts a market cap of $ .76B and has seen a -28.52% loss in value since around the time of its previous earnings announcement.

Investors will also be watching other Drug Delivery stocks with earnings announcements this week like Penwest Pharmaceuticals Co. (PPCO), which will post on Thursday, as well as these others:

Columbia Laboratories Inc. (CBRX) announces Thursday

More...

Be a Fan on Facebook

Follow us on Twitter

Stocks Articles RSS